Trial Profile
TAX [docetaxel] + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Carboplatin; Cisplatin
- Indications Ovarian cancer
- Focus Therapeutic Use
- 16 Oct 2007 New trial record.